AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments

Recent agreement with research organization initiates studies on potential cannabinoid treatments for drug-related psychosis and chemotherapy-related nausea in cancer and AIDS patients. Medical Marijuana, Inc. investment AXIM® Biotechnologies has taken an important step toward the successful creation of cannabinoid-based treatments for a pair of medical conditions. The company has signed an agreement to begin clinical […]